share_log

Compass Diversified Tapped Of Envista Holdings As Finance Chief, Taking Over From Ryan Faulkingham, Effective August 31

Compass Diversified Tapped Of Envista Holdings As Finance Chief, Taking Over From Ryan Faulkingham, Effective August 31

compass diversified招聘envista holdings担任财务总监,自2021年8月31日起接管莱恩·福克汉姆的职位。
Benzinga ·  08/26 06:02

Compass Diversified (NYSE:CODI) ("CODI" or the "Company"), an owner of leading middle market businesses, announced today that Stephen Keller has been appointed as the Company's Chief Financial Officer (CFO), effective August 31, 2024. He will be replacing Ryan Faulkingham, who has served as the Company's CFO since July 2013 and is departing the Company effective August 30, 2024. Mr. Faulkingham will continue to serve in an advisory capacity in order to facilitate a seamless transition.

envista holdings(NYSE: CODI)(" CODI "或" 公司 ")是主要的中市场业务的所有者,宣布斯蒂芬·凯勒(Stephen Keller)于2024年8月31日被任命为公司首席财务官(CFO)。他将取代瑞安·福尔奇汉姆(Ryan Faulkingham),后者自2013年7月以来一直担任该公司的CFO,并于2024年8月30日离开该公司。福尔奇汉将继续以咨询顾问的身份发挥作用,以实现无缝过渡。

In his new role, Mr. Keller will lead CODI's finance organization, including accounting, planning, treasury, tax, reporting, and investor relations. He brings to CODI over 25 years of executive finance experience across multiple industries, including automotive, healthcare, industrial, specialty materials, retail and apparel branding, and media.

在他的新职位上,凯勒先生将领导CODI的财务组织,包括会计、计划、财务、税务、报告和投资者关系。他在多个行业拥有超过25年的高管财务经验,包括汽车、医疗保健、工业、特种材料、零售和服装品牌以及媒体。

Most recently, Mr. Keller served as Interim Chief Financial Officer and Vice President of Investor Relations at Envista Holdings Corporation (NYSE:NVST), a $2.6 billion company and one of the leading suppliers of dental solutions globally. During his time at Envista, he also served as Vice President Strategy and Business Development, as well as Vice President and General Manager of Nobel Biocare's Prosthetics Business Unit.

凯勒先生最近曾担任Envista Holdings Corporation(NYSE: NVST)的临时财务总监兼投资者关系副总裁,该公司是一家26亿美元的公司,也是全球领先的牙科解决方案供应商之一。在Envista担任期间,他还担任战略和业务发展副总裁,以及Nobel Biocare的修复业务部门副总裁兼总经理。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发